The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product?s safety.
The company is halting some pricing practices that critics say were contributing to overuse of its flagship anemia drug Aranesp at a time of mounting concerns about the product?s safety.
The Clinton Foundation announced an agreement among several drug makers that it hopes will assure a supply of a crucial malaria medicine at reasonable prices for the world?s poor.
The Clinton Foundation announced an agreement among several drug makers that it hopes will assure a supply of a crucial malaria medicine at reasonable prices for the world?s poor.
The Clinton Foundation announced an agreement among several drug makers that it hopes will assure a supply of a crucial malaria medicine at reasonable prices for the world?s poor.